| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | EGFR | Synonyms | ERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7p11.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | epidermal growth factor receptor | ||||
| GTO ID | GTC1943 |
| Trial ID | NCT03618381 |
| Disease | Sarcoma | Germ Cell Tumor |
| Altered gene | EGFR|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EGFR806 CAR-T cells|CD19 CAR-T cell |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults |
| Year | 2018 |
| Country | United States |
| Company sponsor | Seattle Children's Hospital |
| Other ID(s) | STRIvE-01 |
| Vector information | |||||
|
|||||
| Cohort1: EGFR | |||||||||
|
|||||||||
| Cohort2: EGFR+CD19 | |||||||||
|
|||||||||